Current Atherosclerosis Reports

, Volume 8, Issue 4, pp 298–303

Management of symptomatic intracranial arterial stenosis: Endovascular therapy



Patients with symptomatic intracranial stenosis are at high risk of subsequent stroke despite the use of antithrombotic agents or surgical management. Although endovascular therapy appears to promise therapeutic solutions, the reported high peri-procedural adverse event rate limits the widespread use of this technique. In the past few years, the morbidity and mortality associated with intracranial angioplasty and stenting have decreased with the development of new intracranial specific devices. The most recent prospective studies on intracranial stenting have been nothing more than registries of patients with symptomatic intracranial stenosis of 50% or greater who have failed medical therapy. However, no randomized controlled data exist on the comparison between endovascular therapy and medical treatment. There are new data identifying factors associated with a higher risk of stroke in medically treated patients. These findings will help to define a high-risk patient population on whom the initial controlled trials will be conducted.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 1985, 313:1191–1200.Google Scholar
  2. 2.
    Bogousslavsky J, Barnett HJ, Fox AJ, et al.: Atherosclerotic disease of the middle cerebral artery. Stroke 1986, 17:1112–1120.PubMedGoogle Scholar
  3. 3.
    Chimowitz MI, Kokkinos J, Strong J, et al.: The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995, 45:1488–1493.PubMedGoogle Scholar
  4. 4.
    Chimowitz MI, Lynn MJ, Howlett-Smith H, et al.: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305–1316.PubMedCrossRefGoogle Scholar
  5. 5.
    Thijs VN, Albers GW: Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000, 55:490–497.PubMedGoogle Scholar
  6. 6.
    Gupta R, Schumacher HC, Mangla S, et al.: Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003, 61:1729–1735.PubMedGoogle Scholar
  7. 7.
    Higashida RT, Meyers PM, Connors JJ, et al.: Intracranial angioplasty and stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. J Vasc Interv Radiol 2005, 16:1281–1285.PubMedGoogle Scholar
  8. 8.
    Kremer C, Schaettin T, Georgiadis D, Baumgartner RW: Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry 2004, 75:1300–1303.PubMedCrossRefGoogle Scholar
  9. 9.
    Kern R, Steinke W, Daffertshofer M, et al.: Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005, 65:859–864.PubMedCrossRefGoogle Scholar
  10. 10.
    Kasner S: Factors associated with a high risk of stroke in the territory of a stenotic intracranial artery in WASID. Program and abstracts of the 30th International Stroke Conference. New Orleans, Louisiana, 2005, February 2–4.Google Scholar
  11. 11.
    Kasner SE, Chimowitz MI, Lynn MJ, et al.: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006, 113:555–563.PubMedCrossRefGoogle Scholar
  12. 12.
    Caplan LR, Gorelick PB, Hier DB: Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986, 17:648–655.PubMedGoogle Scholar
  13. 13.
    Mazighi M, Tanasescu R, Ducrocq X, et al.: Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006, In press.Google Scholar
  14. 14.
    Qureshi AI, Ziai WC, Yahia AM, et al.: Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery 2003, 52:1033–1039.PubMedCrossRefGoogle Scholar
  15. 15.
    Duffy B, Bhatt DL: Antiplatelet agents in patients undergoing percutaneous coronary intervention: how many and how much? Am J Cardiovasc Drugs 2005, 5:307–318.PubMedCrossRefGoogle Scholar
  16. 16.
    Ramee SR, Dawson R, McKinley KL, et al.: Provisional stenting for symptomatic intracranial stenosis using a multidisciplinary approach: acute results, unexpected benefit, and one-year outcome. Catheter Cardiovasc Interv 2001, 52:457–467.PubMedCrossRefGoogle Scholar
  17. 17.
    Connors JJ 3rd, Wojak JC: Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999, 91:415–423.PubMedGoogle Scholar
  18. 18.
    Levy EI, Horowitz MB, Koebbe CJ, et al.: Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001, 48:1215–1221.PubMedCrossRefGoogle Scholar
  19. 19.
    Mori T, Kazita K, Chokyu K, et al.: Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. Am J Neuroradiol 2000, 21:249–254.PubMedGoogle Scholar
  20. 20.
    Abou-Chebl A, Krieger D, Bajzer C, Yadav JS: Intracranial angioplasty and stenting in the awake patient. J Neuroimaging 2006, In press.Google Scholar
  21. 21.
    Clark WM, Barnwell SL, Nesbit G, et al.: Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995, 26:1200–1204.PubMedGoogle Scholar
  22. 22.
    Eckard DA, Zarnow DM, McPherson CM, et al.: Intracranial internal carotid artery angioplasty: technique with clinical and radiographic results and follow-up. Am J Roentgenol 1999, 172:703–707.Google Scholar
  23. 23.
    Marks MP, Marcellus M, Norbash AM, et al.: Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999, 30:1065–1069.PubMedGoogle Scholar
  24. 24.
    Nahser HC, Henkes H, Weber W, et al.: Intracranial vertebrobasilar stenosis: angioplasty and follow-up. Am J Neuroradiol 2000, 21:1293–1301.PubMedGoogle Scholar
  25. 25.
    Sundt TM Jr, Smith HC, Campbell JK, et al.: Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980, 55:673–680.PubMedGoogle Scholar
  26. 26.
    Gomez CR, Misra VK, Campbell MS, Soto RD: Elective stenting of symptomatic middle cerebral artery stenosis. Am J Neuroradiol 2000, 21:971–973.PubMedGoogle Scholar
  27. 27.
    Gomez CR, Misra VK, Liu MW, et al.: Elective stenting of symptomatic basilar artery stenosis. Stroke 2000, 31:95–99.PubMedGoogle Scholar
  28. 28.
    Horowitz MB, Pride GL, Graybeal DF, Purdy PD: Percutaneous transluminal angioplasty and stenting of midbasilar stenoses: three technical case reports and literature review. Neurosurgery 1999, 45:925–930.PubMedCrossRefGoogle Scholar
  29. 29.
    Lanzino G, Fessler RD, Miletich RS, et al.: Angioplasty and stenting of basilar artery stenosis: technical case report. Neurosurgery 1999, 45:404–407.PubMedCrossRefGoogle Scholar
  30. 30.
    Malek AM, Higaschida RT, Halbach VV, et al.: Tandem intracranial stent deployment for treatment of an iatrogenic, flow-limiting, basilar artery dissection: technical case report. Neurosurgery 1999, 45:919–924.PubMedCrossRefGoogle Scholar
  31. 31.
    Morris PP, Martin EM, Regan J, Braden G: Intracranial deployment of coronary stents for symptomatic atherosclerotic disease. Am J Neuroradiol 1999, 20:1688–1694.PubMedGoogle Scholar
  32. 32.
    Rasmussen PA, Perl J 2nd, Barr JD, et al.: Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg 2000, 92:771–778.PubMedCrossRefGoogle Scholar
  33. 33.
    Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004, 35:1388–1392.Google Scholar
  34. 34.
    Alazzaz A, Thornton J, Aletich VA, et al.: Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol 2000, 57:1625–1630.PubMedCrossRefGoogle Scholar
  35. 35.
    Higashida RT, Hieshima GB, Tsai FY, et al.: Transluminal angioplasty of the vertebral and basilar artery. Am J Neuroradiol 1987, 8:745–749.PubMedGoogle Scholar
  36. 36.
    Malek AM, Higashida RT, Phatouros CC, et al.: Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 1999, 30:2073–2085.PubMedGoogle Scholar
  37. 37.
    Terada T, Higashida RT, Halbach VV, et al.: Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatry 1996, 60:377–381.PubMedGoogle Scholar
  38. 38.
    Levy EI, Hanel RA, Bendok BR, et al.: Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg 2002, 97:1294–1301.PubMedGoogle Scholar
  39. 39.
    Lylyk P, Cohen JE, Ceratto R, et al.: Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. Am J Neuroradiol 2002, 23:430–436.PubMedGoogle Scholar
  40. 40.
    Gress DR, Smith WS, Dowd CF, et al.: Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery 2002, 51:23–27.PubMedCrossRefGoogle Scholar
  41. 41.
    Kim JK, Ahn JY, Lee BH, et al.: Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004, 75:847–851.PubMedCrossRefGoogle Scholar
  42. 42.
    Marks MP, Marcellus ML, Do HM, et al.: Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. Am J Neuroradiol 2005, 26:525–530.PubMedGoogle Scholar
  43. 43.
    Henkes H, Miloslavski E, Lowens S, et al.: Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005, 47:222–228.PubMedCrossRefGoogle Scholar
  44. 44.
    Mori T, Fukuoka M, Kazita K, Mori K: Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. Am J Neuroradiol 1998, 19:1525–1533.PubMedGoogle Scholar
  45. 45.
    Bose A: The Wingspan Study. Paper presented at the American Society of Neuroradiology 43rd Annual Meeting. Toronto, Canada, May 23–27, 2005.Google Scholar
  46. 46.
    Yu W, Smith WS, Singh V, et al.: Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 2005, 64:1055–1057.PubMedGoogle Scholar
  47. 47.
    Abou-Chebl A, Bashir Q, Yadav JS: Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 2005, 36:165–168.CrossRefGoogle Scholar
  48. 48.
    Levy EI, Hanel RA, Howington JU, et al.: Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg 2004, 100:688–694.PubMedGoogle Scholar
  49. 49.
    Moreno R, Fernandez C, Hernandez R, et al.: Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005, 45:954–959.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Departments of Neurology and Cardiovascular Medicine, S 90The Cleveland Clinic FoundationClevelandUSA

Personalised recommendations